Vlasova, N.V.,
Masyagutova, L.M.,
Stepanov, E.G.,
Rafikova, L.A.,
Sadrtdinova, G.R.,
Gizatullina, L.G. (2024) of
clinical and laboratory indices as early indicators. The work uses the results of hygienic,
clinicalFedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) cancer and various histological and
clinical characteristics by MS-HRM method. Our results indicate a
, and functional recovery. Early-phase
clinical trials and case studies provide preliminary evidence of safety